By Andrea Anderson

CHICAGO (GenomeWeb News) – Researchers at the Broad Institute are bringing together reams of exome sequence data generated for the Cancer Genome Atlas to get a closer look at germline mutations at play in cancer.

During a presentation at the American Association for Cancer Research annual meeting here yesterday, the Broad's Adam Kiezun said TCGA team members at that center are currently working with more than 100 terabases of exome sequence data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.